This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Musso, O. Articles by Clément, B. Search for Related Content PubMed PubMed Citation Articles by Musso, O. Articles by Clément, B.

Tumor Progression Is Associated with a Significant Decrease in the Expression of the Endostatin Precursor Collagen XVIII in Human Hepatocellular Carcinomas¹

Institut National de la Santé et de la Recherche Médicale U-456, Detoxication and Tissue Repair Unit, Université de Rennes I, 35043 Rennes, France [O. M., N. T., D. L., J-P. C., B. C.]; Collagen Research Unit, Department of Medical Biochemistry, University of Oulu, 90220 Oulu, Finland [M. R., T. P.]; Service d’Anatomie Pathologique B, Hôpital Pontchaillou, 35033 Rennes, France [B. T.]; and Service d’Anatomie Pathologique, Université de Bordeaux 2, 33076 Bordeaux, France [P. B-S.]

Endostatin inhibits angiogenesis and tumor growth in mice. The role of its endogenous precursor collagen XVIII in human cancer is unknown. In normal tissues, two variants of collagen XVIII, namely, the short and long forms regulate tissue specificity, the long form being almost exclusively expressed by hepatocytes in the liver. We analyzed RNA arrays from 57 hepatocellular carcinomas (HCCs) with common and variant-specific probes and investigated the relationships between collagen XVIII expression and angiogenesis by measuring the CD34-positive microvessel density. Low collagen XVIII expression by tumor hepatocytes was associated with large tumor size (r, -0.63; P < 0.001) and replacement of trabeculae with pseudoglandular-solid architecture (², 28; P < 0.001), which indicate tumor progression. Tumors expressing the highest collagen XVIII levels were smaller and had lower microvessel density (P = 0.01) than those expressing moderate levels; and HCCs with the lowest collagen XVIII levels approached a plateau of microvessel density, which indicated that a decrease in collagen XVIII expression is associated with angiogenesis in primary liver cancer. HCCs recurring within 2 years of resection showed 2.2-fold lower collagen XVIII mRNA than nonrecurring ones (P = 0.02). The findings relied on the hepatocyte-specific long form. Thus, the endogenous expression of the endostatin precursor decreases along with tumor progression in HCCs.

This article has been cited by other articles:

				Y. Ohta, R. Waseda, H. Minato, N. Endo, Y. Shimizu, I. Matsumoto, and G. Watanabe Surgical Results in T2N0M0 Nonsmall Cell Lung Cancer Patients With Large Tumors 5 cm or Greater in Diameter: What Regulates Outcome? Ann. Thorac. Surg., October 1, 2006; 82(4): 1180 - 1184. [Abstract] [Full Text] [PDF]

				T. Iizasa, H. Chang, M. Suzuki, M. Otsuji, S. Yokoi, M. Chiyo, S. Motohashi, K. Yasufuku, Y. Sekine, A. Iyoda, et al. Overexpression of Collagen XVIII Is Associated with Poor Outcome and Elevated Levels of Circulating Serum Endostatin in Non-Small Cell Lung Cancer Clin. Cancer Res., August 15, 2004; 10(16): 5361 - 5366. [Abstract] [Full Text] [PDF]

				N. Miosge, T. Simniok, P. Sprysch, and R. Herken The Collagen Type XVIII Endostatin Domain Is Co-localized with Perlecan in Basement Membranes In Vivo J. Histochem. Cytochem., March 1, 2003; 51(3): 285 - 296. [Abstract] [Full Text] [PDF]

				P. Iughetti, O. Suzuki, P. H. C. Godoi, V. A. Ferreira Alves, A. L. Sertie, T. Zorick, F. Soares, A. Camargo, E. S. Moreira, C. di Loreto, et al. A Polymorphism in Endostatin, an Angiogenesis Inhibitor, Predisposes for the Development of Prostatic Adenocarcinoma Cancer Res., October 1, 2001; 61(20): 7375 - 7378. [Abstract] [Full Text] [PDF]